2019 Rx Drug Abuse & Heroin Summit
4-19-2019The annual Rx Drug Abuse & Heroin Summit gathers stakeholders to discuss what’s working in drug abuse prevention and treatment.
Injection Drug Use
Opioid Epidemic Is Increasing Rates of Some Infectious Diseases
4-12-2019The U.S. faces a converging public health crisis as the nation’s opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS.
SAMHSA Funding Opportunity: Increasing Engagement in Substance Use Treatment for Minorities Living with or At-risk for HIV
3-6-2019SAMHSA has issued a funding opportunity announcement to support substance use treatment service delivery to racial/ethnic minority individuals at risk for or li…
SAMHSA Urges Focus on Synergistic Epidemics of Substance Use Disorder, HIV, and Viral Hepatitis
2-13-2019SAMHSA chief urges grantees and partners to address infectious diseases as integral part of the response to the substance use disorders epidemic.
Novel Intervention Halves Rate of Death Among People Living with HIV Who Inject Drugs
9-21-2018An intervention designed to facilitate treatment for HIV and substance use was associated with a 50 percent reduction in mortality for people living with HIV wh…
Substance Use and HIV Risk
8-27-2018Injection drugs and other substances play a role in HIV transmission. Learn why and how to lower that risk.
Dr. Redonna Chandler Selected to Lead AIDS Research Program at NIDA
2-21-2018Dr. Redonna Chandler has been named director of the AIDS Research Program at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Hea…
SAMHSA Funding Opportunity to Integrate Mental Health & Substance Abuse Disorder Treatment with HIV Primary Care and Prevention
1-17-2018The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Mental Health Services (CMHS) is accepting applications for the fiscal…
Syringe Services Programs
9-20-2017The U.S. Department of Health and Human Services (HHS) is committed to working with grantees and partners to reduce the spread of HIV and viral hepatitis in the…
FDA Requests Removal of Opana ER for Risks Related to Abuse
6-29-2017Crossposted from FDA Newsroom
Note: Earlier this month, the FDA requested that a drug company remove an opioid pain medication, Opana ER, from the market becau…